425 MYOSTATIN EFFECTS ON C3H 10T (1/2) MESENCHYMAL MULTIPOTENT CELLS THROUGH THE SMAD SIGNALING PATHWAY: A MICROARRAY APPROACH. (1st January 2006)
- Record Type:
- Journal Article
- Title:
- 425 MYOSTATIN EFFECTS ON C3H 10T (1/2) MESENCHYMAL MULTIPOTENT CELLS THROUGH THE SMAD SIGNALING PATHWAY: A MICROARRAY APPROACH. (1st January 2006)
- Main Title:
- 425 MYOSTATIN EFFECTS ON C3H 10T (1/2) MESENCHYMAL MULTIPOTENT CELLS THROUGH THE SMAD SIGNALING PATHWAY: A MICROARRAY APPROACH.
- Authors:
- Artaza, J. N.
Singh, R.
Braga, M.
Gonzalez-Cadavid, N. - Abstract:
- Abstract : We have shown previously that recombinant myostatin protein (R-Mst) inhibits myogenesis and promotes adipogenesis in C3H 10T (1/2) mesenchymal multipotent cells. In this study we show that myostatin effects in this cell line are mediated through the Smad signaling transduction pathway and some of their downstream components. C3H 10 T (1/2) cells were incubated with 5′-azacytidine to induce differentiation and then treated with 4 μg/mL of R-Mst in a time course manner (0.5, 2, 3, 24 hs and 3 days), using TGF-β (10 ng/mL) as a positive control. Transcriptional regulation of the Smad signaling components was evaluated by a pathway focus designed microarray which has ≈100 genes related to the TGFβ-BMP signaling pathway and by immunocytochemistry (IC) for p-Smad 2/3, 3, 4, and 7. Total RNA from cells treated with R-Mst for 3 Hs and 3 days was analyzed by microarray. In parallel, cells were fixed with paraformaldehyde and analyzed by IC. The main results of the microarray analysis at 3 hs showed that Smad 3, TGFβ1, activins (Inhbb, Ebaf), and Grem1 (signaling regulator molecule) were up-regulated, whereas activin response (Tgif), GDF6, activin (Inhbe), regulator molecule (LAP3), BMP-responsive Smad target genes (Sox4, Dlx2), TGFβ2, and Fst (follistatin), an inhibitor of myostatin activity, were down-regulated, and Smad 1, 2, 5, 6, and -7 did not change. After 3 days of incubation with R-Mst: GDF2 was up-regulated, while Smad target genes (Bambi, DLX2, Cdc25a, Eng, Fos),Abstract : We have shown previously that recombinant myostatin protein (R-Mst) inhibits myogenesis and promotes adipogenesis in C3H 10T (1/2) mesenchymal multipotent cells. In this study we show that myostatin effects in this cell line are mediated through the Smad signaling transduction pathway and some of their downstream components. C3H 10 T (1/2) cells were incubated with 5′-azacytidine to induce differentiation and then treated with 4 μg/mL of R-Mst in a time course manner (0.5, 2, 3, 24 hs and 3 days), using TGF-β (10 ng/mL) as a positive control. Transcriptional regulation of the Smad signaling components was evaluated by a pathway focus designed microarray which has ≈100 genes related to the TGFβ-BMP signaling pathway and by immunocytochemistry (IC) for p-Smad 2/3, 3, 4, and 7. Total RNA from cells treated with R-Mst for 3 Hs and 3 days was analyzed by microarray. In parallel, cells were fixed with paraformaldehyde and analyzed by IC. The main results of the microarray analysis at 3 hs showed that Smad 3, TGFβ1, activins (Inhbb, Ebaf), and Grem1 (signaling regulator molecule) were up-regulated, whereas activin response (Tgif), GDF6, activin (Inhbe), regulator molecule (LAP3), BMP-responsive Smad target genes (Sox4, Dlx2), TGFβ2, and Fst (follistatin), an inhibitor of myostatin activity, were down-regulated, and Smad 1, 2, 5, 6, and -7 did not change. After 3 days of incubation with R-Mst: GDF2 was up-regulated, while Smad target genes (Bambi, DLX2, Cdc25a, Eng, Fos), GDF1, -3, -8, -9, BMP responsive (Idb1), the activin Inhbe, BMP5 and LAP3 were down-regulated, and Fst (folistatin) and Smad 1, 2, 5, 7 remained the same while Smad 3 was undetectable. The results for p-Smad 2/3, 3, 4, and 7 were confirmed by IC, and the results from the microarrays were confirmed by quantitative RT-PCR. In conclusion, myostatin inhibits myogenesis and promotes adipogenesis in C3H 10 T (1/2) cells by signaling through the Smad signaling pathway in an early response since R-Smad 3 (not 2) mRNA and p-Smad 2/3 protein were expressed at 30 min and disappeared thereafter, followed by the subsequent induction of the Smad inhibitor, Smad 7 (not 6) and of downstream Smad-mediated genes. … (more)
- Is Part Of:
- Journal of investigative medicine. Volume 54:Number 1(2006)
- Journal:
- Journal of investigative medicine
- Issue:
- Volume 54:Number 1(2006)
- Issue Display:
- Volume 54, Issue 1 (2006)
- Year:
- 2006
- Volume:
- 54
- Issue:
- 1
- Issue Sort Value:
- 2006-0054-0001-0000
- Page Start:
- S152
- Page End:
- S152
- Publication Date:
- 2006-01-01
- Subjects:
- Clinical medicine -- Periodicals
Medicine -- Research -- Periodicals
Medicine
Research -- United States
Clinical medicine
Medicine -- Research
Periodicals
616.075 - Journal URLs:
- http://journals.lww.com/jinvestigativemed/pages/default.aspx ↗
http://jim.bmj.com/ ↗
https://journals.sagepub.com/home/IMJ ↗
http://journals.lww.com ↗ - DOI:
- 10.2310/6650.2005.X0004.424 ↗
- Languages:
- English
- ISSNs:
- 1081-5589
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5008.010000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 18073.xml